SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001367920-19-000022
Filing Date
2019-04-29
Accepted
2019-04-29 07:22:18
Documents
4
Period of Report
2019-04-29
Effectiveness Date
2019-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2019proxy.htm DEF 14A 576363
2 cncelogoa01.jpg GRAPHIC 11456
3 proxycard2019finalpage1a01.jpg GRAPHIC 95007
4 proxycard2019finalpage2.jpg GRAPHIC 210617
  Complete submission text file 0001367920-19-000022.txt   1009136
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36310 | Film No.: 19773702
SIC: 2834 Pharmaceutical Preparations